D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]-

D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 18916372613
Email: yanzihan@shyuanye.com
Company Name: Beijing Solarbio Science & Tecnology Co., Ltd.  
Tel: 17801761073 18101056239
Email: 3193328036@qq.com
Company Name: MQ (shanghai) Pharmaceuticals Co., Ltd.  
Tel: 13761635123
Email: sales@linyuepharm.com
Company Name: BOC Sciences  
Tel: 16314854226; +8616314854226
Email: inquiry@bocsci.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com

D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- manufacturers

  • BAY 73-1449
  • BAY 73-1449 pictures
  • $37.00
  • 2026-09-10
  • CAS:693790-96-4
  • Purity: 99.77%
  • Supply Ability: 10g
D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- Basic information
Product Name:D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]-
Synonyms:D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]-;BAY 73-1449;vessel,portal,pressure,mesenteric,porto-systemic,inhibit,BAY 731449,blood,BAY 73 1449,prostacyclin,inflow,BAY 73-1449,splenic,Inhibitor,shunt,lower,Prostaglandin Receptor,outflow;BAY 73-1449, 10 mM in DMSO
CAS:693790-96-4
MF:C26H23N3O3
MW:425.48
EINECS:
Product Categories:
Mol File:693790-96-4.mol
D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- Structure
D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- Chemical Properties
Boiling point 700.4±60.0 °C(Predicted)
density 1.273±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO: 250 mg/mL (587.57 mM)
pka3.35±0.10(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- Usage And Synthesis
UsesBAY 73-1449 is a selective antagonist of prostacyclin receptor (IP), with high potency (IC50 of less than 0.1 nM) in cAMP assays in Human HEL cells and rat DRG. BAY 73-1449 can be used in the research of lowering blood pressure[1].
in vivo

BAY 73-1449 (0.1-1 mg/kg; i.v.) does not significantly reduce mesenteric inflow, but significantly reduces splenic shunt vessel outflow in rats[1].
BAY 73-1449 (1-5 mg/kg, s.c. once daily for 7 d) has no effects on the degree of porto-systemic shunting in rats[1].
BAY 73-1449 (1 mg/kg, s.c. once daily for 7 d), has no effects on portal pressures in rats[1].

Animal Model:Male Wistar rats (250-350 g) are ligated portal vein[1]
Dosage:0.1, 1 mg/kg
Administration:A single i.v.
Result:Significantly reduced shunt flow without affecting mesenteric flow.
IC 50IP Receptor: <0.1 nM (IC50)
References[1] Bexis S, et, al. Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat. Eur J Pharmacol. 2008 Aug 20;590(1-3):322-6. DOI:10.1016/j.ejphar.2008.06.006
D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]- Preparation Products And Raw materials
Tag:D-Phenylalanine, N-[6-[4-(phenylmethoxy)phenyl]-4-pyrimidinyl]-(693790-96-4) Related Product Information
15-Keto prostaglandin E2 Bimatoprost Tranilast Grapiprant DG-041 E-7046